Sagliker Syndrome in a Patient With Secondary Hyperparathyroidism and Chronic Kidney Disease: A Case Report From Palestine

被引:1
|
作者
Ahmad, Ibtihal [1 ]
Alkomi, Sala [1 ]
Sharaha, Rula [1 ]
Manasrah, Shaheera [1 ]
Dukmak, Osama N. [2 ]
机构
[1] Palestine Polytech Univ, Sch Med, Nephrol, Internal Med, Hebron, Palestine
[2] Al Quds Univ, Sch Med, Nephrol, Internal Med, Jerusalem, Palestine
关键词
case report; secondary hyperparathyroidism; renal osteodystrophy; chronic kidney disease; sagliker syndrome; HUMAN FACE APPEARANCE; TOTAL PARATHYROIDECTOMY; GENE;
D O I
10.7759/cureus.51956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sagliker syndrome (SS) is a rare complication in patients with chronic kidney disease (CKD) on prolonged dialysis due to uncontrolled secondary hyperparathyroidism (SHPT). SS manifests with a constellation of clinical manifestations, including short stature, craniomaxillofacial abnormalities, hearing loss, and neuropsychiatric disorders. This article reports a 33-year-old male patient with CKD who complained of progressive disfiguring facial changes, multiple recurrent fractures, and shortened height. The condition affects his quality of life. On workup, his lab results showed highly elevated serum levels of parathyroid hormone, alkaline phosphatase (ALP), calcium, and phosphate. His comorbidities and poor health status limit his ability to do parathyroidectomy (Ptx). A reliable diagnostic approach must be considered, enabling physicians to make earlier interventions and get better outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease
    Costa, Tiago Emanuel M.
    Lauar, Julia C.
    Innecchi, Mariana L. R.
    Coelho, Venceslau A.
    Moyses, Rosa M. A.
    Elias, Rosilene M.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (09) : 2255 - 2261
  • [32] Management of Secondary Hyperparathyroidism in Chronic Kidney Disease: A Focus on the Elderly
    Galassi, Andrea
    Ciceri, Paola
    Fasulo, Eliana
    Carugo, Stefano
    Cianciolo, Giuseppe
    Cozzolino, Mario
    DRUGS & AGING, 2019, 36 (10) : 885 - 895
  • [33] Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease
    Galassi, Andrea
    Bellasi, Antonio
    Ciceri, Paola
    Pivari, Francesca
    Conte, Ferruccio
    Cozzolino, Mario
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (10) : 1073 - 1084
  • [34] FGF-23 and secondary hyperparathyroidism in chronic kidney disease
    Silver, Justin
    Naveh-Many, Tally
    NATURE REVIEWS NEPHROLOGY, 2013, 9 (11) : 641 - 649
  • [35] Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease
    Tominaga, Yoshihiro
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2006, 111 (03) : 277 - 292
  • [36] FGF-23 and secondary hyperparathyroidism in chronic kidney disease
    Justin Silver
    Tally Naveh-Many
    Nature Reviews Nephrology, 2013, 9 : 641 - 649
  • [37] Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease
    Naveh-Many, Tally
    Volovelsky, Oded
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 17
  • [38] SARCOIDOSIS, HYPERCALCEMIA AND THEIR INTERPLAY WITH SECONDARY HYPERPARATHYROIDISM IN CHRONIC KIDNEY DISEASE
    Ahmad, Masood
    Jain, Gaurav
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 540 - 540
  • [39] Management of Secondary Hyperparathyroidism in Chronic Kidney Disease: A Focus on the Elderly
    Andrea Galassi
    Paola Ciceri
    Eliana Fasulo
    Stefano Carugo
    Giuseppe Cianciolo
    Mario Cozzolino
    Drugs & Aging, 2019, 36 : 885 - 895
  • [40] Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease
    Salam, S. N.
    Khwaja, A.
    Wilkie, M. E.
    DRUGS, 2016, 76 (08) : 841 - 852